002007 华兰生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.9848.0529.37113.61911.489
总资产报酬率 ROA (%)1.5195.9576.7129.6058.191
投入资产回报率 ROIC (%)1.9407.5838.61912.35710.279

边际利润分析
销售毛利率 (%)50.18857.52961.44969.59066.064
营业利润率 (%)39.17526.73631.50339.28231.536
息税前利润/营业总收入 (%)37.85925.54530.41138.86231.836
净利润/营业总收入 (%)31.83221.76326.38532.97927.620

收益指标分析
经营活动净收益/利润总额(%)74.859104.09193.69692.26298.279
价值变动净收益/利润总额(%)12.8526.61912.73410.08810.085
营业外收支净额/利润总额(%)-3.129-4.704-3.061-0.9990.273

偿债能力分析
流动比率 (X)6.5724.9354.0743.6133.760
速动比率 (X)4.6543.6603.2152.9653.086
资产负债率 (%)9.46412.26115.10316.66917.180
带息债务/全部投入资本 (%)-0.5063.3936.7037.7149.313
股东权益/带息债务 (%)-19,709.0442,828.3171,379.9221,185.620965.910
股东权益/负债合计 (%)822.370614.587481.433423.133410.537
利息保障倍数 (X)-296.8522,565.209-194.623-1,241.805148.579

营运能力分析
应收账款周转天数 (天)216.962140.927168.280152.549161.858
存货周转天数 (天)572.350398.185394.727345.746329.435